AR068628A1 - Tiadiazoles y tiazoles sustituidos, un metodo para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la actividad de la glucocinasa. - Google Patents
Tiadiazoles y tiazoles sustituidos, un metodo para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la actividad de la glucocinasa.Info
- Publication number
- AR068628A1 AR068628A1 ARP080104095A ARP080104095A AR068628A1 AR 068628 A1 AR068628 A1 AR 068628A1 AR P080104095 A ARP080104095 A AR P080104095A AR P080104095 A ARP080104095 A AR P080104095A AR 068628 A1 AR068628 A1 AR 068628A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- formula
- compound
- independently selected
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97422507P | 2007-09-21 | 2007-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR068628A1 true AR068628A1 (es) | 2009-11-25 |
Family
ID=40250949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080104095A AR068628A1 (es) | 2007-09-21 | 2008-09-19 | Tiadiazoles y tiazoles sustituidos, un metodo para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la actividad de la glucocinasa. |
Country Status (29)
Country | Link |
---|---|
US (3) | US8212045B2 (uk) |
EP (4) | EP2573087A1 (uk) |
JP (1) | JP5722037B2 (uk) |
KR (1) | KR101566042B1 (uk) |
CN (1) | CN101868459B (uk) |
AR (1) | AR068628A1 (uk) |
AU (1) | AU2008305294B2 (uk) |
BR (1) | BRPI0816881A2 (uk) |
CA (1) | CA2699718C (uk) |
CO (1) | CO6270223A2 (uk) |
CR (2) | CR11383A (uk) |
DK (1) | DK2209778T3 (uk) |
EA (1) | EA019104B1 (uk) |
ES (2) | ES2569734T3 (uk) |
HK (2) | HK1145498A1 (uk) |
HR (1) | HRP20120814T1 (uk) |
IL (1) | IL204264A (uk) |
MA (1) | MA31779B1 (uk) |
MX (1) | MX2010002772A (uk) |
MY (1) | MY180558A (uk) |
NZ (1) | NZ583538A (uk) |
PL (1) | PL2209778T3 (uk) |
PT (1) | PT2209778E (uk) |
SI (1) | SI2209778T1 (uk) |
TN (1) | TN2010000100A1 (uk) |
TW (1) | TWI423799B (uk) |
UA (1) | UA101166C2 (uk) |
WO (1) | WO2009042435A1 (uk) |
ZA (2) | ZA201002206B (uk) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2131656A4 (en) * | 2006-11-15 | 2011-12-07 | Forest Lab Holdings Ltd | phthalazine |
KR101566042B1 (ko) | 2007-09-21 | 2015-11-04 | 어레이 바이오파마 인크. | 진성 당뇨병을 치료하기 위한 글루코키나제 활성화제로서의 피리딘-2-일-아미노-1,2,4-티아디아졸 유도체 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
CN102959076B (zh) | 2010-03-31 | 2015-09-16 | 斯克里普斯研究所 | 重编程细胞 |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
AU2011293584B2 (en) | 2010-08-23 | 2014-07-31 | Amgen Inc. | Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes |
CA2829187A1 (en) | 2011-03-09 | 2012-09-13 | Daiichi Sankyo Company, Limited | Dipyridylamine derivative |
AU2012240233A1 (en) | 2011-04-05 | 2013-10-10 | Amgen Inc. | Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013123444A1 (en) | 2012-02-17 | 2013-08-22 | Amgen Inc. | Sulfonyl compounds that interact with glucokinase regulatory protein |
WO2013173382A1 (en) | 2012-05-15 | 2013-11-21 | Amgen Inc. | Benzothiophene sulfonamides and other compounds that interact with glucokinase regulatory protein |
CA2877026A1 (en) * | 2012-05-18 | 2013-11-21 | Amgen Inc. | Method for the preparation of thiadiazoles |
CA2890852A1 (en) * | 2012-11-09 | 2014-05-15 | Array Biopharma Inc. | Crystalline forms of (1s)-1-[5-({3-[(2-methylpyridin-3-yl)oxy]-5-(pyridin-2-ylsulfanyl)pyridin-2-yl}amino)-1,2,4-thiadiazol-3-yl]ethane-1,2-diol |
WO2016059647A2 (en) * | 2014-10-13 | 2016-04-21 | SHRI CHHATRAPTI SHIVAJI COLLEGE Maharashtra, India) | Triaminotriazine picolinonitrile derivatives as potent reverse transcriptase inhibitor of hiv-1 |
GB201714777D0 (en) | 2017-09-14 | 2017-11-01 | Univ London Queen Mary | Agent |
CA3080578A1 (en) | 2017-10-30 | 2019-05-09 | Neuropore Therapies, Inc. | Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof |
WO2019228365A1 (zh) | 2018-05-31 | 2019-12-05 | 华领医药技术(上海)有限公司 | 含有葡萄糖激酶激活剂和dpp-iv抑制剂的药物组合、组合物和复方制剂及其制备方法和用途 |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3983246A (en) | 1974-04-04 | 1976-09-28 | Fmc Corporation | N-(sulfonyloxy) benzimidoyl halides as bactericidal or fungicidal agents |
DE2949913A1 (de) * | 1979-12-12 | 1981-06-25 | Basf Ag, 6700 Ludwigshafen | Azofarbstoffe |
EP0300688A1 (en) | 1987-07-21 | 1989-01-25 | FISONS plc | Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them |
JPH0228168A (ja) * | 1988-04-14 | 1990-01-30 | Sankyo Co Ltd | チアゾール誘導体 |
US5326776A (en) * | 1992-03-02 | 1994-07-05 | Abbott Laboratories | Angiotensin II receptor antagonists |
AU4090093A (en) | 1992-05-29 | 1993-12-30 | Yamanouchi Pharmaceutical Co., Ltd. | Medicine containing benzoic acid derivative and novel benzoic acid derivative |
EP0766676B1 (en) | 1994-06-24 | 2002-05-22 | Euroceltique S.A. | Compounds for inhibiting phosphodiesterase iv |
GB9908410D0 (en) * | 1999-04-13 | 1999-06-09 | Pfizer Ltd | Pyridines |
RU2312860C2 (ru) * | 1999-04-15 | 2007-12-20 | Бристол-Маерс Сквибб Компани | Циклические ингибиторы протеинтирозинкиназ |
US7125875B2 (en) * | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
DK1177187T3 (da) | 1999-04-28 | 2007-10-15 | Sanofi Aventis Deutschland | Diarylsyrederivater som PPAR-receptorligander |
WO2000076984A2 (en) | 1999-05-21 | 2000-12-21 | Biovitrum Ab | Novel compounds, their use and preparation |
US6465467B1 (en) * | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
JP4144978B2 (ja) | 1999-09-09 | 2008-09-03 | 富士フイルム株式会社 | 1,2,4−チアジアゾール誘導体の合成法 |
EE200200123A (et) * | 1999-09-10 | 2003-08-15 | Merck & Co., Inc. | Türosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning raviotstarbeline kasutamine |
US20020065270A1 (en) | 1999-12-28 | 2002-05-30 | Moriarty Kevin Joseph | N-heterocyclic inhibitors of TNF-alpha expression |
US6906067B2 (en) | 1999-12-28 | 2005-06-14 | Bristol-Myers Squibb Company | N-heterocyclic inhibitors of TNF-α expression |
IL150420A0 (en) | 1999-12-28 | 2002-12-01 | Pharmacopeia Inc | Pyrimidine and triazine kinase inhibitors |
US7345051B2 (en) | 2000-01-31 | 2008-03-18 | Genaera Corporation | Mucin synthesis inhibitors |
US20050209297A1 (en) * | 2000-08-31 | 2005-09-22 | Pfizer Inc | Pyrazole derivatives |
IL154016A0 (en) | 2000-08-31 | 2003-07-31 | Pfizer Prod Inc | Pyrazole derivatives and their use as protein kinase inhibitors |
CA2425259A1 (en) | 2000-10-11 | 2002-04-18 | Tularik, Inc. | Modulation of ccr4 function |
AU2002213466A1 (en) | 2000-10-11 | 2002-04-22 | Chemocentryx, Inc. | Compounds and methods for modulating ccr4 function |
EP1341773A2 (en) | 2000-12-07 | 2003-09-10 | Cv Therapeutics, Inc. | Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
MXPA03005605A (es) | 2000-12-21 | 2003-10-06 | Vertex Pharma | Compuestos de pirazol utiles como inhibidores de la proteina cinasa. |
US20030130264A1 (en) * | 2001-02-16 | 2003-07-10 | Tularik Inc. | Methods of using pyrimidine-based antiviral agents |
US7144903B2 (en) * | 2001-05-23 | 2006-12-05 | Amgen Inc. | CCR4 antagonists |
PE20030008A1 (es) | 2001-06-19 | 2003-01-22 | Bristol Myers Squibb Co | Inhibidores duales de pde 7 y pde 4 |
CA2450934A1 (en) | 2001-06-19 | 2002-12-27 | Marco Dodier | Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
DE60208792T2 (de) * | 2001-06-22 | 2006-08-31 | Merck & Co., Inc. | Tyrosin-kinase inhibitoren |
WO2003059913A1 (en) | 2002-01-10 | 2003-07-24 | Bayer Healthcare Ag | Roh-kinase inhibitors |
CN1939307A (zh) | 2002-02-05 | 2007-04-04 | 安斯泰来制药有限公司 | 2,4,6-三氨基-1,3,5-三嗪衍生物 |
US6846928B2 (en) * | 2002-03-15 | 2005-01-25 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of protein kinases |
US7179826B2 (en) * | 2002-03-15 | 2007-02-20 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of protein kinases |
DE60332604D1 (de) * | 2002-03-15 | 2010-07-01 | Vertex Pharma | Azolylaminoazine als proteinkinasehemmer |
EP1485100B1 (en) * | 2002-03-15 | 2010-05-05 | Vertex Pharmaceuticals Incorporated | Azinylaminoazoles as inhibitors of protein kinases |
EP1499311B1 (en) | 2002-03-29 | 2009-11-04 | Novartis Vaccines and Diagnostics, Inc. | Substituted benzazoles and use thereof as raf kinase inhibitors |
US8299108B2 (en) | 2002-03-29 | 2012-10-30 | Novartis Ag | Substituted benzazoles and methods of their use as inhibitors of raf kinase |
WO2003091213A1 (fr) * | 2002-04-25 | 2003-11-06 | Yamanouchi Pharmaceutical Co., Ltd. | Derives d'amide ou sels de ces derives |
AU2003249369A1 (en) | 2002-06-21 | 2004-01-06 | Cellular Genomics, Inc. | Certain amino-substituted monocycles as kinase modulators |
CN1691944A (zh) * | 2002-08-09 | 2005-11-02 | 阿斯利康(瑞典)有限公司 | 作为代谢型谷氨酸受体-5调节剂的噁二唑 |
CN1694708A (zh) * | 2002-09-10 | 2005-11-09 | 西奥斯股份有限公司 | TGFβ的抑制剂 |
BR0314864A (pt) | 2002-10-03 | 2005-08-02 | Novartis Ag | Compostos orgânicos |
CA2503715A1 (en) | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Kinase inhibitors |
MXPA05008450A (es) | 2003-02-10 | 2005-10-18 | Vertex Pharma | Procesos para la preparacion de n-heteroaril-n-aril-aminas mediante reaccion de un ester de acido n-aril-carbamico con un halo-heteroarilo y procesos analogos. |
US20040248850A1 (en) * | 2003-02-11 | 2004-12-09 | Kemia, Inc. | Compounds for the treatment of HIV infection |
AU2004220234C1 (en) * | 2003-02-13 | 2013-01-17 | Msd K.K. | Novel 2-pyridinecarboxamide derivatives |
US7276502B2 (en) | 2003-03-25 | 2007-10-02 | Vertex Pharmaceuticals Incorporated | Thiazoles useful as inhibitors of protein kinases |
US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
CA2537141A1 (en) * | 2003-09-02 | 2005-03-10 | Merck And Co., Inc. | Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
US7470712B2 (en) | 2004-01-21 | 2008-12-30 | Bristol-Myers Squibb Company | Amino-benzazoles as P2Y1 receptor inhibitors |
WO2005077373A2 (en) | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Treatment of gastro-esophageal reflux disease (gerd) |
AR049418A1 (es) | 2004-02-27 | 2006-08-02 | Bayer Pharmaceuticals Corp | Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes. |
KR20050091462A (ko) | 2004-03-12 | 2005-09-15 | 한국과학기술연구원 | 푸로피리미딘 화합물 및 이를 포함하는 ddr2 티로신키나아제 활성 저해제 |
CN1934100A (zh) | 2004-03-23 | 2007-03-21 | 万有制药株式会社 | 取代喹唑啉或吡啶并嘧啶衍生物 |
WO2005095417A1 (en) | 2004-04-02 | 2005-10-13 | Novartis Ag | Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
JP2007532676A (ja) | 2004-04-13 | 2007-11-15 | イカジェン インコーポレイテッド | カリウムイオンチャネル調節剤としての多環式ピリジン |
WO2005121126A1 (en) | 2004-04-13 | 2005-12-22 | Icagen, Inc. | Polycyclic pyrazines as potassium ion channel modulators |
TW200606129A (en) * | 2004-07-26 | 2006-02-16 | Chugai Pharmaceutical Co Ltd | Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same |
WO2006071095A1 (en) | 2004-12-31 | 2006-07-06 | Sk Chemicals Co., Ltd. | Quinazoline derivatives for the treatment and prevention of diabetes and obesity |
US7645778B2 (en) | 2005-01-19 | 2010-01-12 | Bristol-Myers Squibb Company | Heteroaryl compounds as P2Y1 receptor inhibitors |
DE102005025161A1 (de) | 2005-06-01 | 2006-12-07 | Phenion Gmbh & Co. Kg | Derivate des Pyrimidins und Triazins und deren Verwendung |
AU2006279376B2 (en) | 2005-08-18 | 2011-04-14 | Vertex Pharmaceuticals Incoporated | Pyrazine kinase inhibitors |
BRPI0615236A2 (pt) * | 2005-08-31 | 2011-05-10 | Astellas Pharma Inc | derivado de tiazol |
WO2007038387A2 (en) | 2005-09-23 | 2007-04-05 | Yale University | Compounds and methods for the treatment of viruses and cancer |
US8933077B2 (en) | 2005-11-01 | 2015-01-13 | Array Biopharma Inc. | Glucokinase activators |
US7820685B2 (en) | 2005-11-03 | 2010-10-26 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
KR20070052207A (ko) | 2005-11-16 | 2007-05-21 | 주식회사 엘지생명과학 | 신규한 kdr 억제제 |
AU2006315334B2 (en) | 2005-11-16 | 2011-05-19 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
ATE539748T1 (de) | 2006-01-27 | 2012-01-15 | Array Biopharma Inc | Glucokinaseaktivatoren |
RU2457207C2 (ru) * | 2006-03-24 | 2012-07-27 | Эррэй Биофарма Инк. | Активаторы глюкокиназы |
DE602007009085D1 (de) | 2006-05-12 | 2010-10-21 | Ab Science | Neues verfahren zur synthese von 2-aminooxazolverbindungen |
WO2008024963A1 (en) | 2006-08-24 | 2008-02-28 | Serenex, Inc. | Benzene, pyridine, and pyridazine derivatives |
TW200825060A (en) | 2006-10-26 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
AU2007333394C1 (en) | 2006-12-08 | 2011-08-18 | Novartis Ag | Compounds and compositions as protein kinase inhibitors |
WO2008091770A1 (en) | 2007-01-24 | 2008-07-31 | Array Biopharma Inc. | 2-aminopyridine derivatives as glucokinase activators |
CN101679405A (zh) | 2007-03-23 | 2010-03-24 | 阵列生物制药公司 | 作为葡萄糖激酶活性剂的2-氨基吡啶类似物 |
AU2008236670B2 (en) | 2007-04-05 | 2011-12-01 | Amgen Inc. | Aurora kinase modulators and method of use |
US20090012091A1 (en) | 2007-07-02 | 2009-01-08 | Kinagen, Inc. | Oximide derivatives and their therapeutical application |
UY31281A1 (es) | 2007-08-13 | 2009-03-31 | Aminas, benzamidas y sulfonamidas {[4-(5,6-dimetil-2-piridin-2-il-piridin-3-il) oxipiridin-2-il]amino} sustituidas, sus sales farmacéuticamente aceptables, composiciones contenniéndolas y aplicaciones. | |
KR101566042B1 (ko) | 2007-09-21 | 2015-11-04 | 어레이 바이오파마 인크. | 진성 당뇨병을 치료하기 위한 글루코키나제 활성화제로서의 피리딘-2-일-아미노-1,2,4-티아디아졸 유도체 |
WO2009046784A1 (en) | 2007-10-09 | 2009-04-16 | Merck Patent Gmbh | Pyridine derivatives useful as glucokinase activators |
-
2008
- 2008-09-15 KR KR1020107008594A patent/KR101566042B1/ko not_active IP Right Cessation
- 2008-09-15 JP JP2010525902A patent/JP5722037B2/ja not_active Expired - Fee Related
- 2008-09-15 ES ES13186328.4T patent/ES2569734T3/es active Active
- 2008-09-15 AU AU2008305294A patent/AU2008305294B2/en not_active Ceased
- 2008-09-15 MX MX2010002772A patent/MX2010002772A/es active IP Right Grant
- 2008-09-15 SI SI200830746T patent/SI2209778T1/sl unknown
- 2008-09-15 UA UAA201004782A patent/UA101166C2/uk unknown
- 2008-09-15 BR BRPI0816881 patent/BRPI0816881A2/pt not_active IP Right Cessation
- 2008-09-15 PL PL08834504T patent/PL2209778T3/pl unknown
- 2008-09-15 EP EP12181665A patent/EP2573087A1/en not_active Withdrawn
- 2008-09-15 US US12/678,995 patent/US8212045B2/en not_active Expired - Fee Related
- 2008-09-15 EP EP16160414.5A patent/EP3078662A1/en not_active Withdrawn
- 2008-09-15 NZ NZ583538A patent/NZ583538A/en not_active IP Right Cessation
- 2008-09-15 EP EP13186328.4A patent/EP2727910B1/en not_active Not-in-force
- 2008-09-15 PT PT88345046T patent/PT2209778E/pt unknown
- 2008-09-15 DK DK08834504.6T patent/DK2209778T3/da active
- 2008-09-15 MY MYPI2010001186A patent/MY180558A/en unknown
- 2008-09-15 EP EP08834504A patent/EP2209778B1/en not_active Not-in-force
- 2008-09-15 CA CA2699718A patent/CA2699718C/en not_active Expired - Fee Related
- 2008-09-15 CN CN2008801169950A patent/CN101868459B/zh not_active Expired - Fee Related
- 2008-09-15 EA EA201000515A patent/EA019104B1/ru not_active IP Right Cessation
- 2008-09-15 ES ES08834504T patent/ES2393824T3/es active Active
- 2008-09-15 WO PCT/US2008/076401 patent/WO2009042435A1/en active Application Filing
- 2008-09-19 TW TW097136197A patent/TWI423799B/zh not_active IP Right Cessation
- 2008-09-19 AR ARP080104095A patent/AR068628A1/es not_active Application Discontinuation
-
2010
- 2010-03-02 IL IL204264A patent/IL204264A/en not_active IP Right Cessation
- 2010-03-04 TN TNP2010000100A patent/TN2010000100A1/fr unknown
- 2010-03-29 ZA ZA2010/02206A patent/ZA201002206B/en unknown
- 2010-04-14 MA MA32775A patent/MA31779B1/fr unknown
- 2010-04-21 CO CO10046631A patent/CO6270223A2/es not_active Application Discontinuation
- 2010-04-21 CR CR11383A patent/CR11383A/es unknown
- 2010-12-24 HK HK10112096.6A patent/HK1145498A1/xx not_active IP Right Cessation
-
2011
- 2011-03-29 ZA ZA2011/02350A patent/ZA201102350B/en unknown
-
2012
- 2012-06-11 US US13/493,616 patent/US8853409B2/en not_active Expired - Fee Related
- 2012-10-11 HR HRP20120814AT patent/HRP20120814T1/hr unknown
-
2014
- 2014-09-23 US US14/494,430 patent/US9079890B2/en not_active Expired - Fee Related
- 2014-11-06 HK HK14111244.5A patent/HK1197821A1/zh not_active IP Right Cessation
-
2015
- 2015-03-12 CR CR20150131A patent/CR20150131A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR068628A1 (es) | Tiadiazoles y tiazoles sustituidos, un metodo para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la actividad de la glucocinasa. | |
JP6505023B2 (ja) | Cnsおよび他の障害を治療するための、pde4アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物 | |
JP2021523221A (ja) | Ptpn11の置換されたヘテロ環式インヒビター | |
KR102189529B1 (ko) | 키누레닌 경로의 억제제 | |
AR088000A1 (es) | Derivados de pirazolquinolinona, su preparacion y su uso terapeutico | |
AR086357A1 (es) | Derivados de indazol sustituidos activos como inhibidores de quinasas | |
AR036103A1 (es) | Imidazotriazinas, procedimiento para su preparacion, uso de dichos compuestos para la manufactura de un medicamento para enfermedades neurodegenerativas y dicho medicamento | |
MX2012002217A (es) | Compuestos heterociclicos como inhibidores de cinasa janus. | |
RU2012104700A (ru) | Азабициклосоединение и его соль | |
AR040473A1 (es) | Derivados de aminoalcoholes, un procedimiento de preparacion, composicion farmaceutica y uso del compuesto para preparar medicamentos | |
ES2714100T3 (es) | Compuestos de quinolina fusionados como inhibidores de mTor, pi3k | |
AR035979A1 (es) | Derivados de quinolina, procedimientos para su preparacion, composiciones farmaceuticas que los comprenden, y usos de dichos compuestos para la preparacion de medicament0s | |
NO20063821L (no) | Kinolinderivater for anvendelse som mykobakterielle inhibitorer | |
CN101484453A (zh) | 咪唑并[1,2-α]吡啶-2-甲酰胺的衍生物,它们的制备和它们在治疗中的用途 | |
JP2022549222A (ja) | アンドロゲン受容体分解活性を有する新規尿素およびその使用 | |
RU2011119525A (ru) | Производные морфолинопурина | |
RU2013109143A (ru) | Бензимидазол- и азабензимидазолсодержащие соединения, которые ингибируют киназу анапластической лимфомы | |
AR079250A1 (es) | Derivados de pirazolo[1,5-a]piridina utiles en el tratamiento de enfermedades del snc y canceres, composiciones farmaceuticas que los contienen e intermediario de sintesis. | |
TW201425311A (zh) | 新穎之雙環吡啶酮 | |
AR067412A1 (es) | Moduladores de propiedades farmaceuticas de productos terapeuticos | |
CN104583197A (zh) | 新型双环吡啶衍生物 | |
RU2013112871A (ru) | Соединения для лечения рака | |
JP6425717B2 (ja) | ガンマセクレターゼモジュレーターとしての新規二環式ピリジノン | |
AR075474A1 (es) | Inhibidores de cyp17 de decahidro-1h-indenoquinolinona y decahidro-3h-ciclopentafenantridinona, composiciones farmaceuticas y metodos de tratamiento | |
EP3319602B1 (en) | Fused quinoline compounds as pi3k/mtor inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal | ||
FB | Suspension of granting procedure |